Showing 3401-3410 of 5689 results for "".
- CEI Vision Partners Adds Virginia Eye Consultants as Fifth Partnerhttps://modernod.com/news/cei-vision-partners-adds-virginia-eye-consultants-as-fifth-partner/2476310/CEI Vision Partners (CVP), a portfolio company of Revelstoke Capital Partners LLC , a Denver-based private equity firm, has completed a partnership with Virginia Eye Consultants (VEC) , a premier multi-specialty ophthalmology group comprised of 17 providers that service the Norfolk, Virginia Beac
- Galimedix Therapeutics Presents Data for Investigational Eyedrops Containing GAL-101https://modernod.com/news/galimedix-therapeutics-presents-data-for-investigational-eyedrops-containing-gal-101/2476320/Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, presented an overview of data disclosed to date on its novel, first-in-class, investigational compound GAL-101, which in animal models caused sustained prevention of misfolded amyloid beta mol
- Bausch Health Reduces Debt By Additional $100 Millionhttps://modernod.com/news/bausch-health-reduces-debt-by-additional-100-million/2476341/Bausch Health Companies, the parent company of Bausch + Lomb, announced it has paid down an additional $100 million of its senior secured term loans using cash generated from operations. “As Bausch Health pivots to offense in 2019, we continue to remain
- Nicox Announces FDA Acceptance of Investigational NDA for NCX 4251 Phase 2 Trial in Blepharitishttps://modernod.com/news/nicox-announces-fda-acceptance-of-investigational-nda-for-ncx-4251-phase-2-trial-in-blepharitis/2479597/Nicox SA announced that the FDA has completed its review of the company’s investigational new drug (IND) application for NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, being developed as the fi
- DORC Unveils Enhancements to the EVA Phacovitrectomy Systemhttps://modernod.com/news/dorc-unveils-enhancements-to-the-eva-phacovitrectomy-system/2476178/DORC has announced the launch several enhancements to its EVA surgical system aimed at delivering both operating room efficiency and surgical performance. The enhancements include a new EVA footswitch that been completely redesigned. Control of the EVA endolaser is now integrated into the
- Aerpio Pharmaceuticals Completes Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathyhttps://modernod.com/news/aerpio-pharmaceuticals-completes-patient-dosing-in-time-2b-study-of-akb-9778-in-diabetic-retinopathy/2476181/Aerpio Pharmaceuticals announced the completion of patient dosing in the company’s TIME-2b study, a phase 2b clinical trial designed to assess the efficacy and safety of Aerpio’s lead candidate, AKB-9778, for patients with moderate to severe nonproliferative diabetic retinopathy (NPDR). &#
- US Democratic Lawmakers Introduce Bills Targeting Drug Pricinghttps://modernod.com/news/us-democratic-lawmakers-introduce-bills-targeting-drug-pricing/2476197/US lawmakers including Senator Bernie Sanders and Representative Elijah Cummings introduced legislation on Thursday seeking to reduce prescription drug prices. “The United States pays by far the highest prices in the world for prescription drugs,” Sen. Sanders commented, adding “
- CooperVision Acquires Blanchard Contact Lenses, Expanding Presence in Specialty Segmenthttps://modernod.com/news/coopervision-acquires-blanchard-contact-lenses-expanding-presence-in-specialty-segment/2476206/CooperVision has acquired Blanchard Contact Lenses, a maker of scleral lenses. Terms of the deal were not disclosed. Blanchard, with its network of distributors, operates in North America, Europe (including Scandinavia), Central America, and South America. Its recently introduced On
- EyeQue Announces Availability of PDCheck on Kickstarter Websitehttps://modernod.com/news/eyeque-announces-availability-of-pdcheck-on-kickstarter-website/2476210/EyeQue, which develops at-home vision tests for smartphones, said this week that its PDCheck tool, a method for measuring pupillary distance (PD), is now available on Kickstarter, according to a
- Healthe Named One of the Nation’s 20 Hottest Health Start-Upshttps://modernod.com/news/healthe-named-one-of-the-nations-20-hottest-health-start-ups/2476213/Healthe, an eye health company that develops products and technology to block ultra-violet and high-energy visible blue light, announced that it was selected by THE OBSERVER as one of the nation’s hottest digital health companies. The list focuses on non-coastal, start-ups from the Midwest, South